These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1768813)

  • 1. Anemia ameliorates progressive renal injury in experimental DOCA-salt hypertension.
    Lafferty HM; Garcia DL; Rennke HG; Troy JL; Anderson S; Brenner BM
    J Am Soc Nephrol; 1991 Apr; 1(10):1180-5. PubMed ID: 1768813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glomerular hypertension and injury in desoxycorticosterone-salt rats on antihypertensive therapy.
    Dworkin LD; Feiner HD; Randazzo J
    Kidney Int; 1987 Mar; 31(3):718-24. PubMed ID: 3573536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anemia lessens and its prevention with recombinant human erythropoietin worsens glomerular injury and hypertension in rats with reduced renal mass.
    Garcia DL; Anderson S; Rennke HG; Brenner BM
    Proc Natl Acad Sci U S A; 1988 Aug; 85(16):6142-6. PubMed ID: 3413082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium carbonate exacerbates glomerular capillary hypertension and injury in rats with desoxycorticosterone-salt hypertension.
    Dworkin LD; Feiner HD; Parker M; Randazzo J
    Am J Hypertens; 1990 Jun; 3(6 Pt 1):444-50. PubMed ID: 2369495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cortical and medullary hemodynamics in deoxycorticosterone acetate-salt hypertensive mice.
    Gross V; Lippoldt A; Bohlender J; Bader M; Hansson A; Luft FC
    J Am Soc Nephrol; 1998 Mar; 9(3):346-54. PubMed ID: 9513896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of nifedipine and enalapril on glomerular injury in rats with deoxycorticosterone-salt hypertension.
    Dworkin LD; Levin RI; Benstein JA; Parker M; Ullian ME; Kim Y; Feiner HD
    Am J Physiol; 1990 Oct; 259(4 Pt 2):F598-604. PubMed ID: 2221099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of amlodipine on glomerular filtration, growth, and injury in experimental hypertension.
    Dworkin LD; Tolbert E; Recht PA; Hersch JC; Feiner H; Levin RI
    Hypertension; 1996 Feb; 27(2):245-50. PubMed ID: 8567047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Is the kidney lesion caused by hypertension really ischemic?].
    Gabbai F; Herrera Acosta J
    Arch Inst Cardiol Mex; 1986; 56(1):81-7. PubMed ID: 2943250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms involved in the progression to glomerular sclerosis induced by systemic hypertension during mild puromycin aminonucleoside nephrosis.
    Amato D; Tapia E; Bobadilla NA; Franco M; Calleja C; García-Torres R; López P; Alvarado JA; Herrera-Acosta J
    Am J Hypertens; 1992 Sep; 5(9):629-36. PubMed ID: 1418851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversing glomerular hypertension stabilizes established glomerular injury.
    Meyer TW; Anderson S; Rennke HG; Brenner BM
    Kidney Int; 1987 Mar; 31(3):752-9. PubMed ID: 3033388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glomerular and vascular lesions in DOCA-salt hypertension: the role of anticoagulation.
    Hewitson T; Kamitsuji H; Whitworth JA; Kincaid-Smith P
    Clin Exp Hypertens A; 1988; 10(4):649-66. PubMed ID: 3390965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of L-type and mixed L- and T-type calcium channel blockers on kidney injury caused by deoxycorticosterone-salt hypertension in rats.
    Baylis C; Qiu C; Engels K
    Am J Kidney Dis; 2001 Dec; 38(6):1292-7. PubMed ID: 11728963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of hypertension on glomerular structures and capillary permeability in passive Heymann glomerulonephritis.
    Iversen BM; Ofstad J
    Microvasc Res; 1987 Sep; 34(2):137-51. PubMed ID: 3670111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic basis for glomerular injury in rats with desoxycorticosterone-salt hypertension.
    Dworkin LD; Hostetter TH; Rennke HG; Brenner BM
    J Clin Invest; 1984 May; 73(5):1448-61. PubMed ID: 6715546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal injury in DOCA-salt hypertensive C5-sufficient and C5-deficient mice.
    Raij L; Dalmasso AP; Staley NA; Fish AJ
    Kidney Int; 1989 Oct; 36(4):582-92. PubMed ID: 2681931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Slowing the progression of chronic renal insufficiency with captopril in rats with spontaneous arterial hypertension and adriamycin nephropathy].
    Jovanović DB; Jovović Dj; Varagić J; Dimitrijević J; Dragojlović Z; Djukanović L
    Srp Arh Celok Lek; 2002; 130(3-4):73-80. PubMed ID: 12154518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat.
    Anderson S; Rennke HG; Brenner BM
    J Clin Invest; 1986 Jun; 77(6):1993-2000. PubMed ID: 3011863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The alpha8 integrin chain affords mechanical stability to the glomerular capillary tuft in hypertensive glomerular disease.
    Hartner A; Cordasic N; Klanke B; Müller U; Sterzel RB; Hilgers KF
    Am J Pathol; 2002 Mar; 160(3):861-7. PubMed ID: 11891185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass.
    Anderson S; Meyer TW; Rennke HG; Brenner BM
    J Clin Invest; 1985 Aug; 76(2):612-9. PubMed ID: 2993362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progressive glomerular injury after limited renal infarction in the rat.
    Meyer TW; Rennke HG
    Am J Physiol; 1988 Jun; 254(6 Pt 2):F856-62. PubMed ID: 3381887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.